Compare SRRK & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRRK | MGY |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.2B |
| IPO Year | 2018 | 2017 |
| Metric | SRRK | MGY |
|---|---|---|
| Price | $40.03 | $29.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $55.10 | $27.85 |
| AVG Volume (30 Days) | 1.1M | ★ 3.0M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | ★ $1,311,845,000.00 |
| Revenue This Year | N/A | $0.70 |
| Revenue Next Year | $449.79 | $9.46 |
| P/E Ratio | ★ N/A | $120.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.71 | $19.09 |
| 52 Week High | $49.82 | $29.69 |
| Indicator | SRRK | MGY |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 68.12 |
| Support Level | $29.32 | $22.71 |
| Resistance Level | $42.54 | $29.69 |
| Average True Range (ATR) | 2.24 | 0.87 |
| MACD | -0.62 | -0.03 |
| Stochastic Oscillator | 1.77 | 89.97 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).